Literature DB >> 27913238

Contemporary ureteroscopic management of renal stones.

S Proietti1, T Knoll2, G Giusti3.   

Abstract

The advancements in the endourological armamentarium and the evolution of ureteroscopes with the advent of fiberoptic first and then digital technology, the introduction of holmium laser lithotripters, together with the increasing number of requests for minimally invasive procedures has ameliorated outcomes, patients' safety and comfort, making the use of flexible ureteroscopy for urinary calculi increasingly attractive and widespread among urological community. Due to its high stone-free rates and low morbidity, flexible ureteroscopy has become a viable option for the treatment of renal stones. This review describes the contemporary ureteroscopic management of kidney stones.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Flexible ureteroscopy; Management; Stones

Mesh:

Year:  2016        PMID: 27913238     DOI: 10.1016/j.ijsu.2016.11.130

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  3 in total

1.  Comparison of the effects of retroperitoneoscopic ureterolithotomy and ureteroscopic lithotripsy in the treatment of upper ureteral calculi.

Authors:  Sheng-Lin Gao; Hao Wu; Quan-Xin Su; Zi-Yi Zhang; Ze Zhang; Chao Lu; Li-Feng Zhang; Li Zuo
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

Review 2.  Tubeless versus standard percutaneous nephrolithotomy: an update meta-analysis.

Authors:  Yang Xun; Qing Wang; Henglong Hu; Yuchao Lu; Jiaqiao Zhang; Baolong Qin; Yudi Geng; Shaogang Wang
Journal:  BMC Urol       Date:  2017-11-13       Impact factor: 2.264

3.  Outcomes of ureteroscopy (URS) for stone disease in the paediatric population: results of over 100 URS procedures from a UK tertiary centre.

Authors:  Patrick Jones; Shazna Rob; Stephen Griffin; Bhaskar K Somani
Journal:  World J Urol       Date:  2019-04-04       Impact factor: 4.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.